Litcius/Paper detail

Plasma β-Amyloid, Total-Tau, and Neurofilament Light Chain Levels and the Risk of Stroke

Alis Heshmatollah, Lana Fani, Peter J. Koudstaal, Mohsen Ghanbari, M. Arfan Ikram, M. Kamran Ikram

2022Neurology22 citationsDOI

Abstract

BACKGROUND AND OBJECTIVES: To unravel whether Alzheimer disease-related pathology or neurodegeneration plays a role in stroke etiology, we determined the effect of plasma levels β-amyloid (Aβ), total-tau, and neurofilament light chain (NfL) on risk of stroke and its subtypes. METHODS: ε4 carriership, and education. RESULTS: ratio levels were not associated with stroke risk. DISCUSSION: Participants with higher total-tau and NfL at baseline had a higher risk of stroke and several stroke subtypes. These findings support the role of markers of neurodegeneration in the etiology of stroke. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that higher plasma levels of total-tau and NfL are associated with an increased risk of subsequent stroke.

Topics & Concepts

MedicineStroke (engine)Internal medicineStroke riskImmunoglobulin light chainNeurofilamentCardiologyPlasma levelsRisk factorChain (unit)PathologyCentral nervous system diseaseClinical neurologyEndocrinologyCase-control studyBlood plasmaRelative riskLifetime riskAlzheimer's disease research and treatmentsIntracerebral and Subarachnoid Hemorrhage ResearchBlood properties and coagulation
Plasma β-Amyloid, Total-Tau, and Neurofilament Light Chain Levels and the Risk of Stroke | Litcius